Idorsia Ltd. (IDRSF)
5.30
0.00 (0.00%)
USD |
OTCM |
Sep 25, 16:00
Idorsia Research and Development Expense (TTM) : 121.31M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 121.31M |
| March 31, 2026 | 114.83M |
| December 31, 2025 | 115.39M |
| September 30, 2025 | 117.53M |
| June 30, 2025 | 125.02M |
| March 31, 2025 | 138.04M |
| December 31, 2024 | 143.47M |
| September 30, 2024 | 171.94M |
| June 30, 2024 | 206.38M |
| March 31, 2024 | 252.49M |
| December 31, 2023 | 315.69M |
| September 30, 2023 | 355.88M |
| June 30, 2023 | 371.90M |
| March 31, 2023 | 384.95M |
| December 31, 2022 | 387.52M |
| September 30, 2022 | 416.53M |
| June 30, 2022 | 429.12M |
| Date | Value |
|---|---|
| March 31, 2022 | 432.28M |
| December 31, 2021 | 436.95M |
| September 30, 2021 | 400.75M |
| June 30, 2021 | 399.37M |
| March 31, 2021 | 399.14M |
| December 31, 2020 | 391.23M |
| September 30, 2020 | 401.75M |
| June 30, 2020 | 409.44M |
| March 31, 2020 | 415.65M |
| December 31, 2019 | 424.71M |
| September 30, 2019 | 438.08M |
| June 30, 2019 | 436.22M |
| March 31, 2019 | 402.90M |
| December 31, 2018 | 368.44M |
| September 30, 2018 | 319.20M |
| June 30, 2018 | 273.60M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Basilea Pharmaceutica AG | 153.18M |
| Santhera Pharmaceuticals Holding AG | 26.72M |
| BeOne Medicines Ltd. | 2.220B |
| AC Immune SA | 57.87M |
| CRISPR Therapeutics AG | 263.69M |